Zosano Pharma Corp
DelistedCIK 1587221fmd_15Z68M51GH26CJ1CYGEXWJVZ2CManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2014 to Mar 31, 2022, 33 periods
| Line item | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|---|---|---|
| Total revenues | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Cost of revenue | – | – | – | – | – | 0 | 0 | 1 |
| Gross profit | – | – | – | – | – | 0 | 0 | (0) |
| Research and development | 11 | 20 | 20 | 20 | 26 | 25 | 22 | 21 |
| Total operating expenses | 15 | 27 | 29 | 28 | 35 | 37 | – | – |
| Operating income | (13) | (26) | (29) | (28) | (35) | (37) | (33) | (32) |
| Interest expense | – | – | – | 1 | 0 | 1 | 1 | 0 |
| Interest and investment income | – | – | – | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income (expense) | (0) | (0) | (0) | 0 | 0 | (0) | 0 | 2 |
| Income before taxes | – | – | (30) | (29) | (35) | (38) | (33) | (30) |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | – | – | (30) | (29) | (35) | (38) | (33) | (30) |
| Net income | (14) | (28) | (30) | (29) | (35) | (38) | (33) | (30) |